| | | |

Mesothelioma Blood Test Could Help Delay Time Between CT Scans

ByAlex Strauss

mesothelioma blood testA mesothelioma blood test could make it possible to stretch the time between CT scans to monitor treatment progress.

That is the conclusion from a team of cancer experts in Italy. The researchers compared the results of the SMRP mesothelioma blood test to CT scans and other prognostic indicators in pleural mesothelioma patients. 

Doctors typically use a set of criteria called mRECIST to assess how well a particular therapy is working. mRECIST includes measurements from CT scans. But CT scans are expensive, time-consuming, and expose patients to ionizing radiation. 

The goal of the new study was to see how closely SMRP levels correlated with mRECIST results. The team says the blood test appears to be accurate enough that it could potentially replace some of the regular CT scans. 

The SMRP Mesothelioma Blood Test

SMRP stands for soluble mesothelin-related peptides. They are breakdown products from proteins in the pleural membrane around the lungs. This membrane is where pleural mesothelioma tumors form. 

The Mesomark test measures SMRP. It is the only FDA-approved biomarker for diagnosing pleural mesothelioma. But it is not complete enough to diagnose pleural mesothelioma by itself. Doctors usually combine a mesothelioma blood test with imaging studies, exams, lung fluid samples and biopsies to make a final mesothelioma diagnosis. 

By plugging information about the cancer into the mRECIST, criteria, doctors can assess changes in mesothelioma tumor burden over time. mRECIST takes into account the number, size, and location of lesions, as well as the levels of different biomarkers. 

Comparing mRECIST and SMRP Levels

To evaluate the value of the SMRP mesothelioma blood test, the Italian team looked at 183 test results and mRECIST scores from 58 pleural mesothelioma patients. When they looked at the results they were “blinded”. This means, they did not know which patients were which. This allowed them to objectively compare the blood tests and other criteria.

“There was a statistically significant correlation between SMRP and mRECIST score in the 2 cohorts considered both separately and jointly,” writes lead author Federica Grosso. 

Dr. Grosso and her team say the mesothelioma blood test might offer a way to monitor pleural mesothelioma with fewer CT scans. This would cut down on both radiation and inconvenience.

“These results, although exploratory, suggest the SMRP measurement might be considered as an adjunct to monitor PM patients in order to delay CT scans time interval,” they write.

This could make treatment monitoring easier and safe for pleural mesothelioma patients and simpler for their doctors. The Italian team concludes that the idea warrants further investigation. 

Early and accurate mesothelioma diagnosis is key to long-term survival. Anyone with mesothelioma symptoms – especially if they have a history of asbestos exposure – should seek medical attention. 

Source:

Grosso, F, et al, “Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesothelioma (PM): Correlation with Modified RECIST Score”, October 29, Diagnostics, Volume 11, Issue 11, https://www.mdpi.com/2075-4418/11/11/2015

Similar Posts

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    ByAlex Strauss

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    ByAlex Strauss

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    ByAlex Strauss

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…

  • |

    Mesothelioma Blood Test May Be Possible

    ByAlex Strauss

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Spanish Mesothelioma Deaths Likely to Continue for Decades

    ByAlex Strauss

    New research in Spain suggests that mesothelioma deaths will continue in the country until the “last surviving member” of the group of people exposed to occupational asbestos succumbs to the disease. Like many countries, Spain used asbestos heavily in the first half of the 20th century, especially in construction, where the mineral was prized for its durability, low cost, and resistance to fire and corrosion.  Asbestos was banned in Spain in 2002. Observing that more than 2.5 million metric tons of asbestos were imported into Spain from 1906 to 2002, researchers say deaths from mesothelioma have risen steadily. Between 1976 and 1980, a total of 491 Spanish people died of mesothelioma. By the 5-year period from 2006 to 2010, that…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    ByAlex Strauss

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…